BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology 2003;37:1267-76. [PMID: 12774004 DOI: 10.1053/jhep.2003.50209] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Satoh T, Uojima H, Wada N, Takiguchi H, Kaneko M, Nakamura M, Gonda N, Homma M, Hidaka H, Kusano C, Horie R. Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia. Platelets 2023;34:2161498. [PMID: 36597279 DOI: 10.1080/09537104.2022.2161498] [Reference Citation Analysis]
2 Lisman T. Bleeding and thrombosis in cirrhosis. Cardio-Hepatology 2023. [DOI: 10.1016/b978-0-12-817394-7.00010-3] [Reference Citation Analysis]
3 Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
4 Satoh T, Takiguchi H, Uojima H, Kubo M, Tanaka C, Yokoyama F, Wada N, Miyazaki K, Hidaka H, Kusano C, Kuwana M, Horie R. B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis. Ann Hematol 2022. [PMID: 36098792 DOI: 10.1007/s00277-022-04973-x] [Reference Citation Analysis]
5 Jang H, Lee YB, Moon H, Chung JW, Nam JY, Cho EJ, Lee JH, Yu SJ, Kim YJ, Lee J, Yoon JH. Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis. Hepatology 2022;76:492-501. [PMID: 35100447 DOI: 10.1002/hep.32380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
6 McMurry HS, Jou J, Shatzel J. The hemostatic and thrombotic complications of liver disease. Eur J Haematol 2021. [PMID: 34258797 DOI: 10.1111/ejh.13688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ding JN, Zhao WF. Mechanism, diagnosis, and treatment of portal vein thrombosis in cirrhosis. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 670-676 [DOI: 10.11569/wcjd.v29.i12.670] [Reference Citation Analysis]
8 Wada N, Uojima H, Satoh T, Okina S, Iwasaki S, Shao X, Takiguchi H, Arase Y, Itokawa N, Atsukawa M, Miyazaki K, Hidaka H, Kako M, Kagawa T, Iwakiri K, Horie R, Suzuki T, Koizumi W. Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease. Dig Dis 2021;39:234-42. [PMID: 32759604 DOI: 10.1159/000510692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen YC, Ko PH, Lee CC, Tseng CW, Tseng KC. Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy. BMC Gastroenterol 2021;21:30. [PMID: 33478399 DOI: 10.1186/s12876-021-01606-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chen YC, Tseng CW, Tseng KC. Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents. Medicine (Baltimore) 2020;99:e20156. [PMID: 32384505 DOI: 10.1097/MD.0000000000020156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
12 Hsu W, Peng C, Su W, Lai H, Lin C, Chuang P, Chen S, Chen H, Wang H, Huang G. Treatment with direct‐acting antiviral agents is associated with increased platelet count in patients with chronic hepatitis C. Adv in Digestive Med 2019;6:109-115. [DOI: 10.1002/aid2.13124] [Reference Citation Analysis]
13 Lei P, Shen G, Wang F, Ning Q, Ren H, Yan W, Wu D. Immunological Features of AECHB. Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1606-0_5] [Reference Citation Analysis]
14 Lisman T, Luyendyk JP. Platelets as Modulators of Liver Diseases. Semin Thromb Hemost 2018;44:114-25. [PMID: 28898899 DOI: 10.1055/s-0037-1604091] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
15 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 20.5] [Reference Citation Analysis]
16 Joo EJ, Chang Y, Yeom JS, Lee YG, Ryu S. Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis. J Viral Hepat 2017;24:253-8. [PMID: 27860000 DOI: 10.1111/jvh.12642] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
17 Gill H, Wong RSM, Kwong YL. From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Ther Adv Hematol 2017;8:159-74. [PMID: 28473904 DOI: 10.1177/2040620717693573] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
18 Satoh T, Kuwana M. Differential Diagnosis: Secondary ITP. Autoimmune Thrombocytopenia 2017. [DOI: 10.1007/978-981-10-4142-6_9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Henry Z, Northup PG. The Rebalanced Hemostasis System in End-stage Liver Disease and Its Impact on Liver Transplantation. International Anesthesiology Clinics 2017;55:107-20. [DOI: 10.1097/aia.0000000000000139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
20 Lisman T. Hemostatic and Non-hemostatic Functions of Platelets in Patients with Liver Disease. Platelets in Thrombotic and Non-Thrombotic Disorders 2017. [DOI: 10.1007/978-3-319-47462-5_78] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Maan R, de Knegt RJ, Veldt BJ. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies. Drugs 2015;75:1981-92. [PMID: 26501978 DOI: 10.1007/s40265-015-0480-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
22 Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, Liu N, Wu H. Hypersplenism: History and current status. Exp Ther Med 2016;12:2377-82. [PMID: 27703501 DOI: 10.3892/etm.2016.3683] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
23 Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?: TRANSFUSION IN CIRRHOSIS. Transfusion 2016;56:791-8. [DOI: 10.1111/trf.13495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
24 Zhang XH, He Y, Feng R, Xu LP, Jiang Q, Jiang H, Lu J, Fu HX, Liu H, Wang JW, Wang QM, Feng FE, Zhu XL, Xu LL, Xie YD, Ma H, Wang H, Liu KY, Huang XJ. Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study. Platelets 2016;27:223-9. [PMID: 26338255 DOI: 10.3109/09537104.2015.1077946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
25 Lesurtel M, Clavien P. Platelets. Signaling Pathways in Liver Diseases 2015. [DOI: 10.1002/9781118663387.ch7] [Reference Citation Analysis]
26 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
27 Senzolo M, Burroughs A. Coagulopathy and clotting disorders. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch22] [Reference Citation Analysis]
28 Potze W, Porte RJ, Lisman T. Management of coagulation abnormalities in liver disease. Expert Rev Gastroenterol Hepatol 2015;9:103-14. [PMID: 24970667 DOI: 10.1586/17474124.2014.934673] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
29 Zhang XH, Feng R, Xu LP, Jiang Q, Jiang H, Fu HX, Liu H, Niu T, Wang X, Hu JD, Jiang M, Wang Z, Wang JW, Ma H, Xie YD, Zhu XL, Wang H, Wei L, Huang XJ. Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study. Platelets 2015;26:672-9. [PMID: 25397356 DOI: 10.3109/09537104.2014.979339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol 2014;28:558-64. [PMID: 25222481 DOI: 10.1155/2014/532191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
31 Klammt S, Mitzner SR, Reisinger EC, Stange J. No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial. Ther Apher Dial 2014;18:502-8. [PMID: 25195684 DOI: 10.1111/1744-9987.12124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Wang X, Jiang W, Li F, Hua F, Zhan Y, Li Y, Ji L, Zou S, Min Z, Song D, Cheng Y. Abnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV-related liver disease. Liver Int 2014;34:535-43. [PMID: 24612171 DOI: 10.1111/liv.12309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kuwana M, Okazaki Y, Ikeda Y. Detection of circulating B cells producing anti-GPIb autoantibodies in patients with immune thrombocytopenia. PLoS One 2014;9:e86943. [PMID: 24466297 DOI: 10.1371/journal.pone.0086943] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
34 Fayed NA, Abdallah AR, Khalil MK, Marwan IK. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets 2014;25:576-86. [PMID: 24246132 DOI: 10.3109/09537104.2013.849335] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
35 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
36 Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 2013;11:1064-74. [PMID: 23506859 DOI: 10.1016/j.cgh.2013.02.026] [Cited by in Crossref: 175] [Cited by in F6Publishing: 184] [Article Influence: 17.5] [Reference Citation Analysis]
37 Ishigami M, Ishizu Y, Onishi Y, Kamei H, Kiuchi T, Itoh A, Hirooka Y, Katano Y, Goto H. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology. Springerplus 2013;2:374. [PMID: 24010032 DOI: 10.1186/2193-1801-2-374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Ren S, Zhang S, Li M, Huang C, Liang R, Jiang A, Guo Y, Pu Y, Huang N, Yang J, Li Z. NF-κB p65 and c-Rel subunits promote phagocytosis and cytokine secretion by splenic macrophages in cirrhotic patients with hypersplenism. Int J Biochem Cell Biol 2013;45:335-43. [PMID: 23195252 DOI: 10.1016/j.biocel.2012.11.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
39 Osaki A, Suda T, Waguri N, Ishikawa T, Yokoo T, Kamimura K, Tamura Y, Takamura M, Igarashi M, Kawai H, Yamagiwa S, Aoyagi Y. Formula to predict platelet count after partial splenic arterial embolization in patients with hypersplenism. J Vasc Interv Radiol 2012;23:900-7. [PMID: 22633618 DOI: 10.1016/j.jvir.2012.03.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
40 Khungar V, Poordad F. Hepatic encephalopathy. Clin Liver Dis 2012;16:301-20. [PMID: 22541700 DOI: 10.1016/j.cld.2012.03.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
41 Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int 2012;32:467-75. [PMID: 22098272 DOI: 10.1111/j.1478-3231.2011.02650.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
42 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
43 Saab S. Hematopoietic Abnormalities and Hemostasis. Zakim and Boyer's Hepatology 2012. [DOI: 10.1016/b978-1-4377-0881-3.00024-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 10.3] [Reference Citation Analysis]
45 Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, De Angelis V, Pozzato G. Platelet production and destruction in liver cirrhosis. J Hepatol 2011;54:894-900. [PMID: 21145808 DOI: 10.1016/j.jhep.2010.08.018] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
46 Flower O, Phillips LE, Cameron P, Gunn K, Dunkley S, Watts A, Rajbhandari D. Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand. Blood Coagul Fibrinolysis 2010;21:207-15. [PMID: 20182351 DOI: 10.1097/MBC.0b013e3283333589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
47 Stanca C, Fiel M, Aledort L, Cohen E, del Rio Martin J, Schiano T. Factors Associated With Persistent Thrombocytopenia after Liver Transplantation. Transplantation Proceedings 2010;42:1769-73. [DOI: 10.1016/j.transproceed.2010.02.075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
48 Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23:1275-1297. [PMID: 19932434 DOI: 10.1016/j.hoc.2009.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
49 Aref S, Sleem T, El Menshawy N, Ebrahiem L, Abdella D, Fouda M, Samara NA, Menessy A, Abdel-Ghaffar H, Bassam A. Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology. 2009;14:277-281. [PMID: 19843383 DOI: 10.1179/102453309x439818] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
50 Desconclois C, Denninger M. Rôle du foie dans l'hémostase. EMC - Hépatologie 2010;5:1-8. [DOI: 10.1016/s1155-1976(10)46311-1] [Reference Citation Analysis]
51 Lesurtel M, Clavien P. Platelets: A New Cell Type in Liver Physiology. Signaling Pathways in Liver Diseases 2010. [DOI: 10.1007/978-3-642-00150-5_7] [Reference Citation Analysis]
52 Jüttner B, Brock J, Weissig A, Becker T, Studzinski A, Osthaus WA, Bornscheuer A, Scheinichen D. Dependence of platelet function on underlying liver disease in orthotopic liver transplantation. Thromb Res 2009;124:433-8. [PMID: 19616824 DOI: 10.1016/j.thromres.2009.06.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
53 Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-S14. [PMID: 19245930 DOI: 10.1053/j.seminhematol.2008.12.005] [Cited by in Crossref: 132] [Cited by in F6Publishing: 150] [Article Influence: 9.4] [Reference Citation Analysis]
54 de Almeida AJ, Campos-de-Magalhães M, Antonietti CL, Brandão-Mello CE, da Silva ML, de Oliveira RV, do Espírito-Santo MP, Yoshida CF, Lampe E. Autoimmune thrombocytopenia related to chronic hepatitis C virus infection. Hematology 2009;14:49-58. [PMID: 19154665 DOI: 10.1179/102453309X385106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
55 Hugenholtz GGC, Porte RJ, Lisman T. The platelet and platelet function testing in liver disease. Clin Liver Dis 2009;13:11-20. [PMID: 19150305 DOI: 10.1016/j.cld.2008.09.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
56 Okada T, Sasaki F, Honda S, Hashimoto S, Kobayashi R, Kaneta M, Todo S. Idiopathic thrombocytopenic purpura complicated with biliary atresia: a rare occurrence and literature review. J Pediatr Surg 2009;44:e21-3. [PMID: 19159705 DOI: 10.1016/j.jpedsurg.2008.09.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 Diaz GC, Prowda J, Lo IJ, Arepally GM, Evans N, Wheeless Y, Samstein B, Guarrera JV, Renz JF. Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors. Liver Transpl 2008;14:1803-9. [PMID: 19025920 DOI: 10.1002/lt.21539] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
58 Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood. 2009;113:4086-4093. [PMID: 19023115 DOI: 10.1182/blood-2008-09-181073] [Cited by in Crossref: 94] [Cited by in F6Publishing: 104] [Article Influence: 6.3] [Reference Citation Analysis]
59 Franchini M, Montagnana M, Targher G, Zaffanello M, Lippi G. The use of recombinant factor VIIa in liver diseases. Blood Coagulation & Fibrinolysis 2008;19:341-8. [DOI: 10.1097/mbc.0b013e32830496a7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
60 Pereboom IT, Lisman T, Porte RJ. Platelets in liver transplantation: friend or foe? Liver Transpl 2008;14:923-31. [PMID: 18581510 DOI: 10.1002/lt.21510] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
61 Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 2008;27:1017-29. [PMID: 18331464 DOI: 10.1111/j.1365-2036.2008.03674.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 7.1] [Reference Citation Analysis]
62 Peck-Radosavljevic M. Review article: coagulation disorders in chronic liver disease. Aliment Pharmacol Ther 2007;26 Suppl 1:21-8. [PMID: 17958516 DOI: 10.1111/j.1365-2036.2007.03509.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
63 Hayashi H, Beppu T, Masuda T, Mizumoto T, Takahashi M, Ishiko T, Takamori H, Kanemitsu K, Hirota M, Baba H. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 2007;22:1638-42. [PMID: 17683504 DOI: 10.1111/j.1440-1746.2007.05090.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
64 Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007;24:250-8. [PMID: 17657149 DOI: 10.1159/000103655] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 7.9] [Reference Citation Analysis]
65 Abdelmalek MF, Hellner LB, Zumberg M, Melgen VW, Lottenberg R. Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection. Dig Dis Sci 2007;52:914-9. [PMID: 17347887 DOI: 10.1007/s10620-006-9319-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol 2006;84:309-15. [PMID: 17118756 DOI: 10.1532/IJH97.06188] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
67 Senzolo M, Burroughs AK. Hemostatic Alterations in Liver Disease and Liver Transplantation. Consultative Hemostasis and Thrombosis 2007. [DOI: 10.1016/b978-141602401-9.10039-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Takahashi T, Miura T, Yamada S, Tsuboi Y, Miura T, Yanagi M. A case of chronic hepatitis C with leukocytopenia and thrombocytopenia that showed sustained virological response to a low-dose consensus interferon treatment. Kanzo 2007;48:498-504. [DOI: 10.2957/kanzo.48.498] [Reference Citation Analysis]
69 Umemura T, Muto H, Tanaka E, Matsumoto A, Ichijo T, Yoshizawa K, Akamatsu T, Kiyosawa K; Nagano Interferon Treatment Research Group. Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C. J Viral Hepat 2007;14:48-54. [PMID: 17212644 DOI: 10.1111/j.1365-2893.2006.00770.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
70 Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, Kuwana M. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007;22:112-8. [PMID: 17201890 DOI: 10.1111/j.1440-1746.2006.04359.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
71 Senzolo M, Burra P, Cholongitas E, Burroughs A. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006; 12(48): 7725-7736 [PMID: 17203512 DOI: 10.3748/wjg.v12.i48.7725] [Cited by in CrossRef: 122] [Cited by in F6Publishing: 127] [Article Influence: 7.2] [Reference Citation Analysis]
72 Arnold HL, Harrison SA. H. pylori and platelet counts. Hepatology 2006;44:1685-7. [PMID: 17133476 DOI: 10.1002/hep.21452] [Reference Citation Analysis]
73 Panzer S, Seel E, Brunner M, Körmöczi GF, Schmid M, Ferenci P, Peck-Radosavljevic M. Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia. Eur J Haematol. 2006;77:513-517. [PMID: 17042765 DOI: 10.1111/j.0902-4441.2006.t01-1-ejh2888.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
74 Panzer S, Seel E, Brunner M, Körmöczi GF, Schmid M, Ferenci P, Peck-radosavljevic M. Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia. Eur J Haematol 2006;0:060928002456001-???. [DOI: 10.1111/j.0902-4441.2006.t01.1-ejh2888.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Kuwana M, Kurata Y, Fujimura K, Fujisawa K, Wada H, Nagasawa T, Nomura S, Kojima T, Yagi H, Ikeda Y. Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study. J Thromb Haemost 2006;4:1936-43. [DOI: 10.1111/j.1538-7836.2006.02091.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
76 Taylor RM, Bockenstedt P, Su GL, Marrero JA, Pellitier SM, Fontana RJ. Immune thrombocytopenic purpura following liver transplantation: a case series and review of the literature. Liver Transpl 2006;12:781-91. [PMID: 16628698 DOI: 10.1002/lt.20715] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
77 Esrailian E, Saab S. Hematopoietic Abnormalities and Hemostasis. Zakim and Boyer's Hepatology 2006. [DOI: 10.1016/b978-1-4160-3258-8.50030-9] [Reference Citation Analysis]
78 Umemura T, Wang RY, Schechterly C, Shih JW, Kiyosawa K, Alter HJ. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. Hepatology 2006;43:91-9. [PMID: 16323211 DOI: 10.1002/hep.20917] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
79 Iga D, Tomimatsu M, Endo H, Ohkawa S, Yamada O. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia. Eur J Haematol. 2005;75:417-423. [PMID: 16191092 DOI: 10.1111/j.1600-0609.2005.00524.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
80 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 3.7] [Reference Citation Analysis]